V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280009987 | 280005082 | null | 58.55 | Palliative (P) | 2017-11-16 | 2017-12-28 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025552 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009988 | 280005084 | null | null | Palliative (P) | 2014-12-17 | 2015-05-28 | CARBOPLATIN | N | N | 280025556 | CARBOPLATIN |
| 280009989 | 280008692 | null | 63 | Adjuvant (A) | 2014-10-31 | 2014-11-04 | STS Non-Rhabdo EpSSG 2005 VBL/MTX | 02 | N | 280025560 | NOT MATCHED |
| 280009990 | 280010413 | 0 | 57 | Palliative (P) | 2017-04-16 | 2017-04-18 | Carboplatin AUC 2 - 5 | null | null | 280025567 | CARBOPLATIN |
| 280009991 | 280005090 | null | null | Palliative (P) | 2013-02-20 | 2013-04-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025571 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009992 | 280008696 | 1.78 | null | Curative (C) | 2016-12-23 | 2017-03-11 | Carboplatin AUC 6 - 10 | 02 | N | 280025571 | CARBOPLATIN |
| 280009993 | 280005092 | 1.8 | 55.3 | Curative (C) | 2017-10-03 | 2017-12-31 | CARBOPLATIN | 02 | N | 280025575 | CARBOPLATIN |
| 280009994 | 280010416 | null | null | Curative (C) | 2014-07-20 | 2014-07-23 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025581 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280009996 | 280005098 | 1.65 | null | Palliative (P) | 2013-02-21 | 2013-10-03 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 280025584 | DOCETAXEL + GEMCITABINE |
| 280009997 | 280005099 | 1.64 | 10 | Palliative (P) | 2016-11-05 | 2016-11-09 | NB HRNBL-1 BUMEL MAT | N | N | 280025588 | NOT MATCHED |
| 280009998 | 280008704 | 1.75 | null | Neo-adjuvant (N) | 2014-12-19 | 2014-12-20 | Docetaxel + Gemcitabine with GCSF | N | null | 280025592 | DOCETAXEL + GEMCITABINE |
| 280009999 | 280005107 | 1.89 | 99 | Palliative (P) | 2014-05-27 | 2014-07-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 280025596 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010000 | 280005110 | 0 | null | Palliative (P) | 2017-07-19 | 2017-08-23 | STS Non-Rhabdo EpSSG 2005 Ifos Dox | null | Y | 280025603 | NOT MATCHED |
| 280010001 | 280008705 | 1.65 | 71 | Palliative (P) | 2015-07-26 | 2015-07-26 | Cetuximab 7 day (>Cycle 2) | N | null | 280025605 | CETUXIMAB |
| 280010002 | 280005114 | 1.76 | 60.75 | Palliative (P) | 2015-06-04 | 2015-07-08 | DOCETAXEL + GEMCITABINE | Y | null | 280025615 | DOCETAXEL + GEMCITABINE |
| 280010004 | 280008707 | 1.84 | 88 | Palliative (P) | 2017-11-06 | 2017-11-23 | EW EuroEwing 2012 Arm B VC | null | null | 280025622 | NOT MATCHED |
| 280010005 | 280005120 | 1.83 | 60 | Palliative (P) | 2017-07-16 | 2017-08-02 | null | N | N | 280025627 | NOT MATCHED |
| 280010006 | 280008709 | 1.8 | 97.5 | Palliative (P) | null | 2016-10-04 | Carboplatin AUC 2 - 5 | N | null | 280025632 | CARBOPLATIN |
| 280010007 | 280005126 | 1.8 | 0 | Palliative (P) | 2016-09-05 | 2016-09-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280025639 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010008 | 280005128 | 0 | 62.7 | Palliative (P) | 2013-07-30 | 2013-08-26 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 280025643 | NOT MATCHED |
| 280010009 | 280005129 | null | 101.5 | Neo-adjuvant (N) | 2014-04-26 | 2014-04-27 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | N | 280025646 | NOT MATCHED |
| 280010010 | 280010427 | 1.77 | 98.7 | Palliative (P) | 2013-03-31 | 2013-04-07 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 280025646 | NOT MATCHED |
| 280010011 | 280005131 | 1.7 | null | Disease modification (D) | 2015-03-02 | 2015-03-11 | EW EuroEwing 2012 Arm B VC | N | N | 280025652 | NOT MATCHED |
| 280010012 | 280005133 | 1.72 | 110.2 | Curative (C) | 2014-11-12 | 2014-11-19 | Cetuximab 7 day (>Cycle 2) | null | null | 280025655 | CETUXIMAB |
| 280010013 | 280005136 | 1.7 | 86 | Neo-adjuvant (N) | 2017-05-25 | 2017-06-13 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | 280025669 | DOCETAXEL + GEMCITABINE |
| 280010014 | 280008719 | 1.64 | null | Palliative (P) | 2014-01-04 | 2014-01-22 | Cetuximab 7 day (>Cycle 2) | N | N | 280025672 | CETUXIMAB |
| 280010015 | 280011898 | 1.71 | null | null | 2018-08-18 | 2018-08-28 | Cetuximab 7 day (>Cycle 2) | N | N | 280025706 | CETUXIMAB |
| 280010016 | 280005147 | 1.58 | 9.5 | Curative (C) | 2014-02-20 | 2014-03-09 | CETUXIMAB | N | N | 280025726 | CETUXIMAB |
| 280010017 | 280005148 | 1.65 | 72 | Palliative (P) | 2017-09-10 | 2018-02-22 | Cetuximab 7 day (>Cycle 2) | N | null | 280025728 | CETUXIMAB |
| 280010018 | 280005152 | 1.74 | 55.3 | null | 2014-11-30 | 2014-12-24 | WT SIOP 2002 01 post op VAV | 01 | N | 280025730 | NOT MATCHED |
| 280010019 | 280011273 | 1.64 | 34.2 | Palliative (P) | 2016-08-12 | 2016-08-24 | Docetaxel + Gemcitabine (prior RT) | 01 | N | 280025738 | DOCETAXEL + GEMCITABINE |
| 280010020 | 280005154 | null | 94 | Neo-adjuvant (N) | 2014-02-04 | 2014-02-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025740 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010021 | 280005158 | 1.86 | 89.4 | Palliative (P) | 2016-07-22 | 2016-07-23 | Docetaxel + Gemcitabine with GCSF | 02 | N | 280025744 | DOCETAXEL + GEMCITABINE |
| 280010022 | 280005160 | null | 51.8 | Palliative (P) | 2017-05-02 | 2017-05-31 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025749 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280010023 | 280005164 | 1.51 | 50.6 | Palliative (P) | 2014-11-08 | 2014-11-18 | DOCETAXEL + GEMCITABINE | N | N | 280025754 | DOCETAXEL + GEMCITABINE |
| 280010024 | 280005165 | 1.7 | null | Curative (C) | null | 2017-07-22 | Cetuximab 14 day | 02 | N | 280025755 | CETUXIMAB |
| 280010025 | 280005167 | 1.79 | 88.8 | Curative (C) | 2014-12-18 | 2014-12-24 | Olaratumab | Y | N | 280025758 | NOT MATCHED |
| 280010026 | 280005170 | null | null | 3 | 2016-06-20 | 2016-09-06 | CARBOPLATIN | Y | N | 280025770 | CARBOPLATIN |
| 280010027 | 280005171 | 1.7 | 57.8 | Palliative (P) | 2017-05-28 | 2017-06-12 | Cetuximab 7 day (>Cycle 2) | 01 | N | 280025782 | CETUXIMAB |
| 280010028 | 280005174 | 0 | 80 | Curative (C) | 2015-07-25 | 2016-02-27 | null | null | null | 280025789 | NOT MATCHED |
| 280010029 | 280005177 | null | null | Palliative (P) | 2017-02-15 | 2017-03-12 | NB HRNBL-1 COJEC Ind COURSE A | N | null | 280025794 | NOT MATCHED |
| 280010030 | 280005182 | 1.77 | null | Palliative (P) | 2017-01-06 | 2017-01-06 | Doxorubin 50mg/m2 | null | null | 280025800 | DOXORUBICIN |
| 280010031 | 280005183 | 1.63 | 68 | Curative (C) | null | 2015-10-21 | Cetuximab + Radiotherapy Maint | 2 | Y | 280025801 | CETUXIMAB + RT |
| 280010032 | 280005184 | 1.73 | null | Neo-adjuvant (N) | 2017-08-03 | 2017-11-23 | DOXORUBICIN | N | N | 280025810 | DOXORUBICIN |
| 280010033 | 280008742 | 1.56 | 76.1 | Palliative (P) | 2017-04-26 | 2017-05-01 | Ifosfamide | N | N | 280025812 | IFOSFAMIDE |
| 280010034 | 280005188 | 1.8 | null | Palliative (P) | 2016-10-01 | 2016-11-24 | Cisplatin | 02 | Y | 280025818 | CISPLATIN |
| 280010035 | 280008745 | 1.69 | 91 | Palliative (P) | 2013-06-16 | 2013-06-19 | Paclitaxel 7 day | null | null | 280025821 | PACLITAXEL |
| 280010036 | 280005194 | 1.53 | 111 | null | 2014-05-29 | 2015-09-27 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280025828 | RMS 2005 TRIAL |
| 280010037 | 280011277 | 1.73 | null | Palliative (P) | 2015-08-12 | 2015-08-27 | DOXORUBICIN | N | N | 280025832 | DOXORUBICIN |
| 280010038 | 280005196 | 0 | 90.5 | Curative (C) | 2016-08-21 | 2016-08-22 | IVA | Y | Y | 280025836 | IVA |